Dedicated to Research Since 1993

Global Orthobiologics Market by Product (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-rich Protein, Bone Marrow Aspirate Concentrate) by End Users (Hospitals and Orthopedic Clinics and Ambulatory Care, Centers Research and Academic Institutes, Dental Clinics and Facilities) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Orthobiologics Market was valued at USD XX billion in the year 2017. Global Orthobiologics market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.

In the Global Orthobiologics Market, by region, North America region holds the highest market share in 2017 and Asia Pacific market is considered as the fastest growing market in the forecasted period owing to their market demands. At the country level, the China, and Japan in Asia-Pacific are projected to grow strongly in the coming years due to high-end aerospace applications.


            Increasing Incidence of Sports Injuries and Road Accidents

            Rising Geriatric and Obese Population


            High Costs Associated With Orthobiologics-based Treatments


            Emerging Markets


            Side Effects Associated With Bmp-Based Treatments

The segmentation is done on the basis of product, application, end user and by region. On the basis of the product, the market is categorized into allografts, synthetic orthobiologics, PRP, BMAC, DBM, BMP, and viscosupplementation products. Of these products, the viscosupplementation segment is expected to hold the highest market share during the forecast period due to high-performance adhesives.

Based on application, the market is segmented into fracture recovery, osteoarthritis & degenerative arthritis, spinal fusion, soft-tissue injuries, and maxillofacial & dental applications. The osteoarthritis & degenerative arthritis segment is estimated to command the largest share of the global orthobiologics market in 2017.

Arthrex Inc. (U.S), Bioventus LLC (U.S),Depuy Synthes (A Subsidiary of Johnson & Johnson) (U.S),Globus Medical Inc. (U.S),Harvest Technologies Corporation (A Terumo Bct Company)K2M Group Holdings Inc. (U.S),Kuros Biosciences Ltd (Switzerland), Medtronic PLC (U.S),Nuvasive Inc. (U.S), Orthofix International NV (U.S) are some of the key players in the Global Orthobiologics market.

Key Benefits for Stakeholders

Orthobiologics Product Manufacturing Companies

Product Suppliers, Distributors, and Channel Partners

Hospitals and Ambulatory Care Centers

Orthopedic and Dental Clinics

Research and Consulting Organization

Government and Non-government Organizations

By Product

Viscosupplementation Products

Demineralized Bone Matrices

Synthetic Orthobiologics

Bone Morphogenic Protein


Plasma-rich Protein

Bone Marrow Aspirate Concentrate

By Application

Osteoarthritis and Degenerative Arthritis

Spinal Fusion

Soft-tissue Injuries

Fracture Recovery

Maxillofacial and Dental Applications

By End Users

Hospitals, Orthopedic Clinics, and Ambulatory Care Centers

Research and Academic Institutes

Dental Clinics and Facilities

By Region

North America




Key Market Players

Arthrex Inc.

Bioventus LLC

Depuy Synthes (A Subsidiary of Johnson & Johnson)

Globus Medical Inc.

Harvest Technologies Corporation (A Terumo Bct Company)

K2M Group Holdings Inc.

Kuros Biosciences Ltd

Medtronic PLC

Nuvasive Inc.

Orthofix International NV

 (A brief overview of 10 companies is also provided)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

    Key Data from Secondary Research

       2.1.2. Primary Research

    Key Data from Primary Research

    Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Orthobiologics Market, By Product

6.1 Viscosupplementation Products

6.2 Demineralized Bone Matrices

6.3 Synthetic Orthobiologics

6.4 Bone Morphogenic Protein

6.5 Allografts

6.6 Plasma-rich Protein

6.7 Bone Marrow Aspirate Concentrate

7. Orthobiologics Market, By Application

7.1 Osteoarthritis and Degenerative Arthritis

7.2 Spinal Fusion

7.3 Soft-tissue Injuries

7.4 Fracture Recovery

7.5 Maxillofacial and Dental Applications

8. Orthobiologics Market, By End Users

8.1 Hospitals, Orthopedic Clinics, and Ambulatory Care Centers

8.2 Research and Academic Institutes

8.3 Dental Clinics and Facilities

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. U.K.

       9.3.2. Germany

       9.3.3. France

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. South Korea

       9.4.2. China

       9.4.3. Japan

       9.4.4. RoAPAC

9.5. RoW

       9.5.1. Latin America

       9.5.2. Middle East and Africa

10. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

10.1 Arthrex Inc.

10.2 Bioventus LLC

10.3 Depuy Synthes (A Subsidiary of Johnson & Johnson)

10.4 Globus Medical Inc.

10.5 Harvest Technologies Corporation (A Terumo Bct Company)

10.6 K2M Group Holdings Inc.

10.7 Kuros Biosciences Ltd

10.8 Medtronic PLC

10.9 Nuvasive Inc.

10.10 Orthofix International NV

(A brief overview of 10 companies is also provided.)

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.


No Content Available.



Related Reports